Birdwatch Note
2025-04-07 18:04:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Budesinode is a steroid, the precautions for its use specifically list measles as a contraindication. “This medicine may weaken your immune system. Avoid being around people who are sick or who have infections such as chickenpox or measles.” https://www.mayoclinic.org/drugs-supplements/budesonide-inhalation-route/description/drg-20071233
Written by 193281C84C2CFBBE0D0B26B3C75074A812B24D9D05F9709ACEDD4BAB0FB2EF96
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1909049021211263268
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1909306314351656969
- noteId - 1909306314351656969
- participantId -
- noteAuthorParticipantId - 193281C84C2CFBBE0D0B26B3C75074A812B24D9D05F9709ACEDD4BAB0FB2EF96
- createdAtMillis - 1744049073194
- tweetId - 1909049021211263268
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Budesinode is a steroid, the precautions for its use specifically list measles as a contraindication. “This medicine may weaken your immune system. Avoid being around people who are sick or who have infections such as chickenpox or measles.” https://www.mayoclinic.org/drugs-supplements/budesonide-inhalation-route/description/drg-20071233
Note Ratings
rated at | rated by | |
2025-04-08 05:59:07 -0500 | Rating Details | |
2025-04-07 21:32:23 -0500 | Rating Details | |
2025-04-07 19:18:40 -0500 | Rating Details | |
2025-04-07 15:52:04 -0500 | Rating Details | |
2025-04-20 10:56:58 -0500 | Rating Details | |
2025-04-09 13:48:01 -0500 | Rating Details | |
2025-04-08 19:21:48 -0500 | Rating Details | |
2025-04-08 11:58:19 -0500 | Rating Details | |
2025-04-08 07:39:09 -0500 | Rating Details | |
2025-04-08 07:00:13 -0500 | Rating Details | |
2025-04-07 21:43:52 -0500 | Rating Details | |
2025-04-07 15:51:54 -0500 | Rating Details | |
2025-04-08 06:08:13 -0500 | Rating Details | |
2025-04-08 05:37:52 -0500 | Rating Details | |
2025-04-07 14:48:27 -0500 | Rating Details | |
2025-04-07 13:59:56 -0500 | Rating Details | |
2025-04-07 13:50:42 -0500 | Rating Details | |
2025-04-11 16:08:35 -0500 | Rating Details | |
2025-04-09 09:25:48 -0500 | Rating Details | |
2025-04-08 20:46:20 -0500 | Rating Details | |
2025-04-07 20:23:38 -0500 | Rating Details | |
2025-04-07 20:03:38 -0500 | Rating Details | |
2025-04-07 18:40:23 -0500 | Rating Details | |
2025-04-07 18:06:13 -0500 | Rating Details | |
2025-04-08 06:33:52 -0500 | Rating Details | |
2025-04-07 16:15:47 -0500 | Rating Details | |
2025-04-08 00:52:50 -0500 | Rating Details | |
2025-04-07 23:33:24 -0500 | Rating Details | |
2025-04-07 22:17:12 -0500 | Rating Details | |
2025-04-19 06:04:32 -0500 | Rating Details | |
2025-04-08 23:02:56 -0500 | Rating Details | |
2025-04-08 00:59:21 -0500 | Rating Details | |
2025-04-07 17:54:56 -0500 | Rating Details | |
2025-04-20 11:34:37 -0500 | Rating Details | |
2025-04-20 10:27:11 -0500 | Rating Details | |
2025-04-07 23:15:12 -0500 | Rating Details | |
2025-04-07 14:37:22 -0500 | Rating Details | |
2025-04-07 14:25:59 -0500 | Rating Details | |
2025-04-07 14:07:34 -0500 | Rating Details | |
2025-04-07 13:11:33 -0500 | Rating Details | |
2025-04-30 09:52:56 -0500 | Rating Details | |
2025-04-10 12:25:59 -0500 | Rating Details | |
2025-04-08 12:33:43 -0500 | Rating Details | |
2025-04-08 05:20:29 -0500 | Rating Details | |
2025-04-08 01:36:07 -0500 | Rating Details | |
2025-04-08 00:05:23 -0500 | Rating Details | |
2025-04-07 18:06:03 -0500 | Rating Details | |
2025-04-10 02:59:27 -0500 | Rating Details | |
2025-04-08 07:32:07 -0500 | Rating Details | |
2025-04-10 17:58:25 -0500 | Rating Details | |
2025-04-08 18:38:27 -0500 | Rating Details | |
2025-04-08 19:43:18 -0500 | Rating Details | |
2025-04-08 17:44:23 -0500 | Rating Details | |
2025-04-08 04:16:06 -0500 | Rating Details | |
2025-04-08 05:01:13 -0500 | Rating Details | |
2025-04-08 05:39:40 -0500 | Rating Details | |
2025-04-09 06:39:04 -0500 | Rating Details | |
2025-06-23 03:47:45 -0500 | Rating Details |